Pricing Log in Create free account

Cocrystal Pharma, Inc. (COCP) vs Seres Therapeutics, Inc. (MCRB)

Cocrystal Pharma, Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. Cocrystal Pharma, Inc. and Seres Therapeutics, Inc. are of similar size ($20.8M and $19.3M). Cocrystal Pharma, Inc. grew revenue faster over the last twelve months: −30.4% against −98.3%. Cocrystal Pharma, Inc. has the higher net margin (−747.8% vs −2,209.6%) and the higher return on invested capital (0.00% vs −1,267.8%). Across the 17 metrics below, Cocrystal Pharma, Inc. leads on 10 and Seres Therapeutics, Inc. on 7.

Valuation

Metric COCP MCRB Biotechnology median
P/E n/m n/m 10.60
P/S 10.69 9.25 9.40
P/B 13.60 0.92 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 9.00 49.24 9.02
Earnings yield (73.79%) (253.88%) (32.88%)
Free cash flow yield (56.09%) (323.94%) (23.13%)

Profitability

Metric COCP MCRB Biotechnology median
Gross margin 9.10% 100.00% 68.51%
Operating margin (760.72%) (3,656.89%) 0.00%
Net margin (747.78%) (2,209.55%) 0.00%
Free cash flow margin (598.50%) (2,997.74%) 0.00%
Return on equity (311.68%) (144.35%) (51.96%)
Return on assets (151.10%) (44.85%) (46.06%)
Return on invested capital 0.00% (1,267.77%) 0.00%

Growth

Metric COCP MCRB Biotechnology median
Revenue growth (TTM) (30.38%) (98.33%) 6.76%
EPS growth (last fiscal year) 54.65% 0.00% 29.88%
Revenue growth, 5-year CAGR (33.30%) (53.03%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COCP MCRB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.24 1.65 4.97
Net debt to EBITDA 0.82 0.51 1.01

Dividend

Metric COCP MCRB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric COCP MCRB Biotechnology median
Market cap 19.27m 20.78m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack